Clinical Trial Update: Role of Esophagectomy in Complete Responders to CCRT [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether esophagectomy benefits patients who completely respond to concurrent chemoradiotherapy for esophageal squamous cell carcinoma; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Asan Medical Center | Conditions: Esophageal Squamous Cell Carcinoma | Phase 3 | Status: TERMINATED